Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$244M |
| 2 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$143M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$137M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$109M |
| 5 |
VMW
VMware, Inc
VMW
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Apple
AAPL
|
+$763M |
| 3 |
Microsoft
MSFT
|
+$618M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$592M |
| 5 |
AABA
Altaba Inc
AABA
|
+$393M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.41% |
| 2 | Healthcare | 5.88% |
| 3 | Financials | 5.51% |
| 4 | Consumer Discretionary | 4.79% |
| 5 | Communication Services | 4.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
PUT
Pultegroup
PHM
$25.3B
| $572K | ﹤0.01% |
19,900
-12,400
| -38% | -$373K |
|
|
OPB
3752
DELISTED
Opus Bank Common Stock
OPB
| $572K | ﹤0.01% |
19,937
+1,391
| +8% | +$40.1K |
|
|
IDTI
3753
CALL
DELISTED
Integrated Device Technology I
IDTI
| $571K | ﹤0.01% |
17,900
-40,300
| -69% | -$1.28M |
|
|
BBT
3754
Beacon Financial Corp
BBT
$2.67B
| $568K | ﹤0.01% |
13,984
+5,583
| +66% | +$221K |
|
3755
First Commonwealth Financial
FCF
$2.18B
| $568K | ﹤0.01% |
36,677
+2,960
| +9% | +$45.5K |
|
3756
Fortuna Silver Mines
FSM
$3.07B
| $568K | ﹤0.01% |
99,967
+92,376
| +1,217% | +$517K |
|
3757
Paylocity
PCTY
$8.03B
| $566K | ﹤0.01% |
9,605
-299
| -3% | -$17.1K |
|
|
CBIO
3758
PUT
Crescent Biopharma
CBIO
$624M
| $565K | ﹤0.01% |
+350
| New | +$602K |
|
3759
Intrepid Potash
IPI
$472M
| $565K | ﹤0.01% |
13,763
+5,809
| +73% | +$254K |
|
3760
CALL
Trimble
TRMB
$13.8B
| $565K | ﹤0.01% |
17,200
+7,900
| +85% | +$274K |
|
|
NE
3761
PUT
DELISTED
Noble Corporation
NE
| $565K | ﹤0.01% |
89,200
-60,200
| -40% | -$308K |
|
|
THR
3762
DELISTED
Thermon Group Holdings
THR
| $564K | ﹤0.01% |
24,672
-6,614
| -21% | -$155K |
|
|
OTIC
3763
DELISTED
Otonomy, Inc.
OTIC
| $564K | ﹤0.01% |
146,360
+1,981
| +1% | +$8.24K |
|
3764
PUT
Aon
AON
$75.9B
| $562K | ﹤0.01% |
4,100
-14,700
| -78% | -$2.07M |
|
3765
PUT
Exelon
EXC
$47.1B
| $562K | ﹤0.01% |
18,506
-11,076
| -37% | -$317K |
|
3766
US Physical Therapy
USPH
$1.22B
| $562K | ﹤0.01% |
5,837
-2,030
| -26% | -$188K |
|
|
AUY
3767
PUT
DELISTED
Yamana Gold, Inc.
AUY
| $562K | ﹤0.01% |
193,900
-43,500
| -18% | -$126K |
|
|
XENT
3768
CALL
DELISTED
Intersect ENT, Inc
XENT
| $562K | ﹤0.01% |
+15,000
| New | +$589K |
|
3769
PUT
iShares MSCI Germany ETF
EWG
$1.62B
| $561K | ﹤0.01% |
18,700
-7,200
| -28% | -$232K |
|
3770
Teladoc Health
TDOC
$1.3B
| $561K | ﹤0.01% |
9,666
-7,815
| -45% | -$382K |
|
|
DVAX
3771
DELISTED
Dynavax Technologies
DVAX
| $559K | ﹤0.01% |
36,721
-6,862
| -16% | -$119K |
|
|
RDUS
3772
PUT
DELISTED
Radius Recycling
RDUS
| $559K | ﹤0.01% |
16,600
+11,800
| +246% | +$376K |
|
|
GPOR
3773
CALL
DELISTED
Gulfport Energy Corp.
GPOR
| $559K | ﹤0.01% |
44,500
-17,400
| -28% | -$180K |
|
3774
Federated Hermes
FHI
$4.72B
| $557K | ﹤0.01% |
23,928
-2,351
| -9% | -$62.8K |
|
3775
Ionis Pharmaceuticals
IONS
$9.37B
| $556K | ﹤0.01% |
13,355
-51,490
| -79% | -$2.28M |
|
Similar funds
Barclays's Q2 2018 Portfolio in Review
As of Q2 2018, Barclays held 7,691 positions worth $116B, down 11% from $131B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays withdrew a net $18.4B in Q2 2018, closing 585 positions and reducing 3,613 holdings. Its most notable exit was Time Warner Inc, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 8.6% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in Evergy worth $42M.
- Barclays's largest Q2 2018 buy was Evergy: 747,502 shares worth $42M.
- Barclays added most to State Street Industrial Select Sector SPDR ETF in Q2 2018, an estimated $244M increase.
- Barclays's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- Barclays fully exited Time Warner Inc in Q2 2018, selling an estimated $290M.
- Barclays's ten largest holdings make up 27% of its $116B portfolio in Q2 2018.
- Barclays opened 402 new positions and closed 585 in Q2 2018.
- Barclays's portfolio value fell 11% quarter-over-quarter to $116B.
Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.